Trials / Conditions / Advanced Or Metastatic Merkel Cell Carcinoma
Advanced Or Metastatic Merkel Cell Carcinoma
3 registered clinical trials studyying Advanced Or Metastatic Merkel Cell Carcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants Wit NCT06947928 | TuHURA Biosciences, Inc. | Phase 2 / Phase 3 |
| Recruiting | IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC) NCT06940440 | TuHURA Biosciences, Inc. | Phase 1 |
| Terminated | Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cu NCT03684785 | Exicure, Inc. | Phase 1 / Phase 2 |